These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11779278)

  • 1. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia.
    Suhara T; Okubo Y; Yasuno F; Sudo Y; Inoue M; Ichimiya T; Nakashima Y; Nakayama K; Tanada S; Suzuki K; Halldin C; Farde L
    Arch Gen Psychiatry; 2002 Jan; 59(1):25-30. PubMed ID: 11779278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
    Talvik M; Nordström AL; Olsson H; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):361-70. PubMed ID: 14604451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of D2 dopamine receptors in schizophrenia: the ups and downs of neuroimaging research.
    Wong DF
    Arch Gen Psychiatry; 2002 Jan; 59(1):31-4. PubMed ID: 11779279
    [No Abstract]   [Full Text] [Related]  

  • 4. Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.
    Kaasinen V; Någren K; Hietala J; Oikonen V; Vilkman H; Farde L; Halldin C; Rinne JO
    Neurology; 2000 Apr; 54(7):1482-7. PubMed ID: 10751262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects.
    Hagelberg N; Aalto S; Kajander J; Oikonen V; Hinkka S; Någren K; Hietala J; Scheinin H
    Pain; 2004 May; 109(1-2):86-93. PubMed ID: 15082129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of extrastriatal dopamine D2 receptors in schizophrenia.
    Takahashi H; Higuchi M; Suhara T
    Biol Psychiatry; 2006 May; 59(10):919-28. PubMed ID: 16682269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
    Olsson H; Halldin C; Farde L
    Neuroimage; 2004 Jun; 22(2):794-803. PubMed ID: 15193608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
    Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrastriatal dopamine D2-receptor availability in social anxiety disorder.
    Plavén-Sigray P; Hedman E; Victorsson P; Matheson GJ; Forsberg A; Djurfeldt DR; Rück C; Halldin C; Lindefors N; Cervenka S
    Eur Neuropsychopharmacol; 2017 May; 27(5):462-469. PubMed ID: 28377075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia.
    Xiberas X; Martinot JL; Mallet L; Artiges E; Canal M; Loc'h C; Mazière B; Paillère-Martinot ML
    J Clin Psychopharmacol; 2001 Apr; 21(2):207-14. PubMed ID: 11270918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and gender.
    Glenthoj BY; Mackeprang T; Svarer C; Rasmussen H; Pinborg LH; Friberg L; Baaré W; Hemmingsen R; Videbaek C
    Biol Psychiatry; 2006 Sep; 60(6):621-9. PubMed ID: 16580642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.
    Olsson H; Farde L
    Neuroimage; 2001 Oct; 14(4):936-45. PubMed ID: 11554812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457.
    Okubo Y; Olsson H; Ito H; Lofti M; Suhara T; Halldin C; Farde L
    Neuroimage; 1999 Dec; 10(6):666-74. PubMed ID: 10600412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors.
    Halldin C; Farde L; Högberg T; Mohell N; Hall H; Suhara T; Karlsson P; Nakashima Y; Swahn CG
    J Nucl Med; 1995 Jul; 36(7):1275-81. PubMed ID: 7790956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
    Buchsbaum MS; Christian BT; Lehrer DS; Narayanan TK; Shi B; Mantil J; Kemether E; Oakes TR; Mukherjee J
    Schizophr Res; 2006 Jul; 85(1-3):232-44. PubMed ID: 16713185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.
    Hietala J; Syvälahti E; Vuorio K; Någren K; Lehikoinen P; Ruotsalainen U; Räkköläinen V; Lehtinen V; Wegelius U
    Arch Gen Psychiatry; 1994 Feb; 51(2):116-23. PubMed ID: 7905257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of [11 C]FLB 457 binding in extrastriatal regions.
    Sudo Y; Suhara T; Inoue M; Ito H; Suzuki K; Saijo T; Halldin C; Farde L
    Nucl Med Commun; 2001 Nov; 22(11):1215-21. PubMed ID: 11606887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.
    Aalto S; Hirvonen J; Kaasinen V; Hagelberg N; Kajander J; Någren K; Seppälä T; Rinne JO; Scheinin H; Hietala J
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):475-83. PubMed ID: 18985345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.